Nat Prod Sci.  2019 Dec;25(4):285-292. 10.20307/nps.2019.25.4.285.

Pharmaceutical Studies on “Dang-Gui” in Korean Journals

• Ahn J
• Ahn MJ
• Chin YW
• Kim J

• KMID: 2468060
• DOI: http://doi.org/10.20307/nps.2019.25.4.285

Abstract

A crude drug "Dang-Gui", belonging to the genus Angelica, has been used as a traditional herbal medicine in Asia. Various studies have investigated the chemical components and pharmacological activities of Dang-Gui worldwide. However, domestic research results published in Korean are undervalued in international academia due to language barriers. Therefore, it is necessary to summarize the domestic research findings systematically for greater accessibility. This review focuses on the results published in four Korean pharmaceutical journals between 1970 and 2018, which detail the botanical, phytochemical, and pharmacological properties of three Angelica species (A. gigas, A. sinensis, and A. acutiloba) used as "Dang-Gui" in Korea, China, and Japan.

Keyword

Dang-Gui; Angelica gigas; Angelica sinensis; Angelica acutiloba; phytochemical; pharmacological; Korean journal

MeSH Terms

Angelica
Angelica sinensis
Asia
China
Communication Barriers
Herbal Medicine
Japan
Korea

Figure

• 

  Fig. 1 Compounds from three Angelica species, Angelica gigas, A. sinensis and A. acutiloba.

Reference

1. The Korean Pharmacopoeia. 11th Ed. Republic of Korea: Ministry of Food and Drug Safety;2014. p. 1790.

2. The Japanese Pharmacopoeia. 16th Ed. Japan: The Ministry of Health Labor and Welfare;2012. p. 1866.

3. Pharmacopoeia of the People's Republic of China; National Pharmacopoeia Commission of the People's Republic of China. China: China Medical Science Press;2015. p. 133.

4. Park JH, Lee YJ, Keon SJ. Korean J Pharmacogn. 2005; 36:141–144.

5. Ahn MJ, Bae JY, Park JH. Korean J Pharmacogn. 2011; 42:103–106.

6. Kim HJ, Piao XL, Jang YP. Nat Prod Sci. 2011; 17:202–205.

7. Kim HM, Kang JS, Park SK, Lee K, Kim JY, Kim YJ, Hong JT, Kim Y, Han SB. Arch Pharm Res. 2008; 31:1489–1496.

8. Lee S, Shin DS, Kim JS, Oh KB, Kang SS. Arch Pharm Res. 2003; 26:449–452.

9. Lee S, Kang SS, Shin KH. Nat Prod Sci. 2002; 8:58–61.

10. Kang SY, Kim YC. Arch Pharm Res. 2007; 30:1368–1373.

11. Yook CS, Kim CW, Ryu KS. Korean J Pharmacogn. 1973; 4:189–190.

12. Lee YY, Lee S, Jin JL, Yun-Choi HS. Arch Pharm Res. 2003; 26:723–726.

13. Ryu KS, Hong ND, Kim NJ, Kong YY. Korean J Pharmacogn. 1990; 21:64–68.

14. Lee JH, Choi YS, Kim JS, Kim JH, Jeong HG, Kim DH, Yun MY, Kim JS, Cho SH, Shen GN, Kim EG, Jin WY, Song GY. Yakhak Hoeji. 2006; 50:172–176.

15. Moon HI, Ahn KT, Lee KR, Zee OP. Yakhak Hoeji. 2000; 44:119–127.

16. Lee S, Kang SS, Shin KH. Nat Prod Sci. 2002; 8:127–128.

17. Roh J, Lim H, Shin S. Nat Prod Sci. 2012; 18:244–249.

18. Chi HJ, Kim HS. Korean J Pharmacogn. 1988; 19:239–247.

19. Chen QC, Lee JP, Jin WY, Youn UJ, Kim HJ, Lee IS, Zhang XF, Song KS, Seong YH, Bae KH. Arch Pharm Res. 2007; 30:565–569.

20. Park RJ, Kim NJ, Lee KT, Seo SH. Korean J Pharmacogn. 2001; 32:72–78.

21. Son CY, Baek IH, Song GY, Kang JS, Kwon KI. Yakhak Hoeji. 2009; 53:303–313.

22. Kim NS, Jeong SI, Kim JS, Oh MJ, Oh CH. Korean J Pharmacogn. 2016; 47:197–203.

23. Lee S, Lee YS, Jung SH, Shin KH, Kim BK, Kang SS. Arch Pharm Res. 2003; 26:727–730.

24. Kim HM, Kang JS, Park SK, Lee K, Kim JY, Kim YJ, Hong JT, Kim Y, Han SB. Arch Pharm Res. 2008; 31:1489–1496.

25. Kim CM, Heo MY, Kim HP, Sin KS, Pachaly P. Arch Pharm Res. 1991; 14:87–92.

26. Kim YA, Park SH, Kim BY, Kim AH, Park BJ, Kim JJ. Korean J Pharmacogn. 2014; 45:209–213.

27. Lee S, Lee YS, Jung SH, Shin KH, Kim BK, Kang SS. Nat Prod Sci. 2003; 9:170–173.

28. Kim YK, Cho KH, Shon YH, Choi HK, Kim SY, Lim JK, Nam KS. Yakhak Hoeji. 2000; 44:283–292.

29. Woo WS, Shin KH, Ryu KS. Arch Pharm Res. 1980; 3:79–84.

30. Shin KH, Han JM, Lee IR. Korean J Pharmacogn. 1996; 27:323–327.

31. Chung MH, Oh HS, Lim JH. Korean J Pharmacogn. 1998; 29:402–412.

32. Chung MH, Lim JH, Oh HS. Korean J Pharmacogn. 1998; 29:300–311.

33. Ahn KS, Sim WS, Kim HM, Han SB, Kim IH. Korean J Pharmacogn. 1996; 27:254–261.

34. Cho CH, Kim SJ, Kim HJ. Yakhak Hoeji. 2002; 46:161–167.

35. Kim JR, Lee DY, Sung SH, Kim J. Korean J Pharmacogn. 2013; 44:332–335.

36. Kang YG, Lee JH, Chae HJ, Kim DH, Lee S, Park SY. Korean J Pharmacogn. 2003; 34:201–205.

37. Lee JP, Chang SY, Park SY. Nat Prod Sci. 2004; 10:262–267.